Similar effects were observed for GFAP (Figure 4A), where 4 of AD 6 cases showed significantly higher local GFAP immunoreactivity compared to only 1 of 3 control cases (Figure 4B). The gene discussed is GFAP; the disease is Alzheimer disease.